Journal
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 1, Issue 7, Pages 1094-1096Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/b301175p
Keywords
-
Categories
Ask authors/readers for more resources
The asymmetric hydrogenation of a selectively crystallised (E)-4,4-diaryl-3-butenoate with a rhodium-PhanePhos catalyst is described, providing an intermediate to the antidepressant sertraline.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available